Circulating Tumour Cells in Patients With Peritoneal Metastases
NCT04083547 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 114
Last updated 2020-11-04
Summary
This study aims to evaluate the prognostic value of circulating tumour cells (CTC) in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy due to gastrointestinal cancers that have spread to the peritoneum.
Conditions
- Circulating Tumor Cell
- Peritoneal Metastases
- Hyperthermic Intraperitoneal Chemotherapy
Interventions
- DIAGNOSTIC_TEST
-
iCellate
New method of circulating tumour cell detection and capture.
Sponsors & Collaborators
-
Uppsala University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-10-17
- Primary Completion
- 2019-10-01
- Completion
- 2020-11-01
Countries
- Sweden
Study Locations
More Related Trials
-
Combined Anticancer Treatment of Advanced Colon Cancer
NCT01540344 ·Status: TERMINATED ·Phase: PHASE2
-
Prophylactic HIPEC for Colorectal Cancers at High Risk of Developing Peritoneal Metastases
NCT03422432 ·Status: COMPLETED ·Phase: NA
-
Adjuvant HIPEC to Prevent Colorectal Peritoneal Metastases in High-risk Patients
NCT02575859 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Patient-tailored Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases (OrganoHIPEC)
NCT06057298 ·Status: UNKNOWN ·Phase: NA
-
Pathophysiology of Inflammation After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
NCT02741167 ·Status: UNKNOWN
-
Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal Metastasis
NCT04157322 ·Status: ACTIVE_NOT_RECRUITING
-
Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer
NCT04180761 ·Status: WITHDRAWN ·Phase: PHASE2
-
Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers
NCT06967961 ·Status: RECRUITING ·Phase: NA
-
Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis
NCT04370925 ·Status: RECRUITING ·Phase: PHASE3
-
Microparticles in Peritoneal Carcinomatosis of Colorectal Origin
NCT03969784 ·Status: COMPLETED ·Phase: NA
-
Prospective Randomized Trial Evaluating Mandatory Second Look Surgery With HIPEC and CRS vs. Standard of Care in Subjects at High Risk of Developing Colorectal Peritoneal Metastases
NCT01095523 ·Status: WITHDRAWN ·Phase: PHASE2
-
Surgery for Gastrointestinal Metastases of Malignant Melanoma - a Single Center Retrospective Cohort Study
NCT03879395 ·Status: COMPLETED
-
Cytoreduction Followed by Normothermic Versus Hyperthermic Intraperitoneal Intraoperative Chemoperfusion (HIPEC): a Study in Peritoneal Carcinomatosis
NCT01575730 ·Status: COMPLETED ·Phase: PHASE2
-
Radical Colorectal Resection and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Colorectal Cancer
NCT02830139 ·Status: COMPLETED ·Phase: PHASE2
-
Prophylactic Preoperative HIPEC in Advanced Gastric Cancer at High Risk of Peritoneal Recurrence
NCT04597294 ·Status: RECRUITING ·Phase: PHASE3
-
NeoRes Study - Preoperative Chemotherapy in Colorectal Peritoneal Disease Prior to Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
NCT06903039 ·Status: COMPLETED
-
An Audit of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
NCT02754115 ·Status: RECRUITING
-
HIPEC and Systemic Chemotherapy in Unresectable Peritoneal Metastases From Colorectal Cancer
NCT03398512 ·Status: TERMINATED ·Phase: NA
-
Surgery With HIPEC in Treating Patients With a High Risk of Developing Colorectal Peritoneal Carcinomatosis
NCT02179489 ·Status: COMPLETED ·Phase: NA
-
Research of Circulating Tumor Cells Released During Endometrial Cancer Surgery.
NCT04021459 ·Status: COMPLETED ·Phase: NA
-
Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stomach CAncer: a Feasibility Study
NCT03150628 ·Status: TERMINATED ·Phase: PHASE2
-
Locally Advanced Rectal Cancer - Exfoliated Peritoneal Tumor Cells
NCT02113384 ·Status: ACTIVE_NOT_RECRUITING
-
Late Organ Specific Adverse Effects hiPec or pElvic eXenteration
NCT04970316 ·Status: UNKNOWN
-
Micrometastasis in Gastrointestinal Cancer
NCT01919151 ·Status: UNKNOWN
-
Patient Derived Vascularized MicroTumor Model of Gastrointestinal Peritoneal Carcinomatosis
NCT05844865 ·Status: RECRUITING ·Phase: NA